Cooperation and trust are key in getting partners to work well together as part of a coordinated care organization (CCO), said Christine Bernsten, senior manager of delivery systems transformation for Health Share of Oregon.
Cooperation and trust are key in getting partners to work well together as part of a coordinated care organization (CCO), said Christine Bernsten, senior manager of delivery systems transformation for Health Share of Oregon.
Transcript (slightly modified)
Health Share has 16 different plan partners with individual contracts. How do you coordinate all of those entities?
So there are 16 different plan partners that are part of Health Share and many, many more provider organizations, so it’s a lot of different people to come together trying to achieve common goals. And it was challenging in the beginning, a lot of the initial focus was on creating relationships, identifying easy opportunities to reduce administrative burden, make things easier for providers and patients as well.
And I think we’ve been successful over time by choosing small things to work on, showing success, and that develops trust among the partners and makes you want to take on bigger projects, bigger opportunities for integration, and continue to refine your relationships working together.
What challenges did Health Share of Oregon face in the beginning?
So one of the biggest challenges is provider buy-in, and just getting a lot of different organizations to work together and agree on what the goals are, agree on how we’re going to approach those together, and really develop that trust and have some positive successes together. But I think people were skeptical in the beginning and CCOs have started to show places where they really can bring value to serving the Medicaid population and so people are more willing to continue working together.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
2 Commerce Drive
Cranbury, NJ 08512